|

TB Wonder Drug That Shortens Treatment Span to Be Tested (India)
The Times of India, May 6, 2008, by Kounteya Sinha
Moxifloxacin, a fluoroquinolone antibiotic, may be part of a clinical trial to determine whether the drug increases the TB cure rate and shortens treatment time. The study will recruit 2, 400 new TB patients in over 20 sites in the world. Melvin Spigelman, Director of Research and Development for the Global Alliance for TB Drug Development, said that four sites in South Africa, Zambia, and Tanzania are recruiting patients for the study. Read more [+/-]
Cases of Drug-Resistant TB Have Doubled, Study Shows (United Kingdom)
The Guardian, May 2, 2008, by Ian Sample
According to a Health Protection Agency study of 28,620 TB cases in England, Wales, and Northern Ireland, resistant strains of TB nearly doubled between 1998 and 2005. The number of people with TB disease resistant to at least one major drug increased from 170 in 1998 to 336 in 2005. More than 8,000 TB cases were reported in England, Wales, and Northern Ireland in 2007. Read more [+/-]
|

|